Women's Health in the Time of COVID-19 Webinar
Uncovering how the coronavirus affects the biology of women and men differently is teaching us new ways to fight COVID-19. Identifying how the stress of the pandemic is different for women and men is focusing mental health professionals on risk and resilience. Watch Women’s Health Research at Yale Director Carolyn M. Mazure, Ph.D, and leading immunologist Akiko Iwasaki, Ph.D., in conversation with Yale Medalist Susanna Krentz, '80, as they discuss a major new research finding and next steps in investigating sex differences to advance the health of women and men.
Why Is COVID-19 Striking Men Harder Than Women?
Women's Health Research at Yale Director Carolyn M. Mazure and Immunobiology Professor Akiko Iwasaki, discuss how understanding why men suffer more severe cases of COVID-19 and are more likely to die is vital for developing effective strategies that can produce better outcomes for everyone.Source: Time
From the Gut: How Beneficial Bacteria Inside Our Bodies Might Trigger and Treat Autoimmune Disease
Two years after obtaining a Women’s Health Research at Yale seed grant, Dr. Martin Kriegel has continued exploring how beneficial bacteria that live in the gut might trick the body into an autoimmune reaction known as antiphospholipid syndrome.
Outsmarting Herpes: Researchers Use the Body's Natural Defenses to Stop Outbreaks
Ever since receiving the first of two seed grants from Women’s Health Research at Yale in 2003, Dr. Akiko Iwasaki’s lab has established groundbreaking insights into the transmission, treatment and possible prevention of herpes.
Eleven Yale faculty honored by Connecticut Academy of Science and Engineering
Eleven Yale faculty are among 23 individuals recently elected to the Connecticut Academy of Science and Engineering. Members of the academy are considered Connecticut's leading experts in science, engineering, and technology.
Vishwa Deep Dixit, DVM, PhD, Appointed Director of the Yale Center for Research on Aging (Y-Age) and Professor of Pathology at Yale Pathology
Vishwa Deep Dixit, DVM, PhD, the Waldemar Von Zedtwitz Professor of Comparative Medicine and Immunobiology at Yale School of Medicine, will be appointed as Director of the Yale Center for Research on Aging (Y-Age) and Professor of Pathology on January 1, 2022.
Ask tough questions: PhD student Sebastian Diaz
Sebastian Diaz, a PhD student in immunobiology at Yale School of Medicine (YSM), said it’s hard to be among the pioneers, but because medical students from underrepresented backgrounds have pushed for greater emphasis on diversity, equity, and inclusion (DEI) supported by resources “We have a very robust system that is now becoming bigger and bigger every year.”
Common Cold Could Protect Against COVID In Early Stages Of Infection
t’s hard to envision the common cold, caused by rhinoviruses, as something of a superhero, but recent research from Yale University has found this bug to have an intriguing effect on the early success of the pathogen that causes COVID-19 in the body.Source: IFLScience
The Role of Viperin in Viral Protection with Dr. Chun-Chieh ‘Jack’ Hsu
Chun-Chieh ‘Jack’ Hsu, Ph.D., a CRI postdoctoral fellow in the lab of Peter Cresswell, Ph.D., at Yale University, is investigating a protein named viperin that helps promote the elimination of viral infection and is even found in some cancers. But much about viperin and its mechanisms remains unknown, so he’s exploring how it influences immune responses, which could pave the way for future strategies to protect against both viruses and cancers.Source: Cancer Research Institute
How T Cells Make Sure They Have Quiet Time
All cells, like all people, need “quiet” time to function properly, and this is particularly true of T cells, one of the immune system’s main weapons. They must be ready for activation at all times, and primed to divide more rapidly than almost any cell in the body.
The harmful effects of stress during pregnancy can last a lifetime
Mice exposed to stress in the womb and soon after birth can expect a lifetime of immune system deficiencies that hinder the ability to ward off infections and cancer, Yale University researchers report March 5 in the journal Cell.
From Paradox to Breakthrough
Aaron Ring, MD, PhD, was hooked by a paradox. He had been studying cytokines to understand their potential to stimulate anti-tumor immunity. Though cytokines, such as interleukin-2, have been in clinical use for decades, they have historically shown only limited effectiveness. Dr. Ring was hunting for interleukins that could deliver a specific signal to activate TILs.